Academic or other sponsor

Johns Hopkins University

34 registered trials on this registry, 12 recruiting now. An academic sponsor is usually answering a scientific question rather than seeking approval, which changes what its trials are designed to show.

Registered trials

Recruiting

In Phase 3

With results posted

Working on

Substances

Trials

All 34 trials

Trial	Status	Phase	Substance	Sites
Effects of Psilocybin on Electrophysiology and the Dynamic Content of ThoughtNCT05301608 · Johns Hopkins University	Recruiting	Phase 1 / Phase 2	psilocybin	1
Psilocybin Efficacy With or Without Pimavanserin PretreatmentNCT07610135 · Johns Hopkins University	Recruiting	Phase 1 / Phase 2	psilocybin	1
Outpatient Buprenorphine Induction With Psilocybin for Opioid Use DisorderNCT06067737 · Johns Hopkins University	Recruiting	Phase 2	psilocybin	1
5-HT2A Agonist Psilocybin in the Treatment of Tobacco Use DisorderNCT05452772 · Johns Hopkins University	Recruiting	Phase 2	psilocybin	3
Psilocybin in Chronic Low Back Pain and DepressionNCT06355414 · Johns Hopkins University	Recruiting	Phase 1	psilocybin	1
Psilocybin-assisted Treatment for Cannabis Use DisorderNCT06660381 · Johns Hopkins University	Recruiting	Phase 1	psilocybin	1
Investigation of Psychedelic Effects in Psychoactive SubstancesNCT06772753 · Johns Hopkins University	Recruiting	Phase 1	psilocybin, mdma, dmt	1
Psychedelic Healing: Adjunct Therapy Harnessing Opened MalleabilityNCT07053917 · Johns Hopkins University	Recruiting	Phase 1	psilocybin	1
Psilocybin and Methylenedioxymethamphetamine (MDMA) for Post-traumatic Stress Disorder (PTSD)NCT06989957 · Johns Hopkins University	Recruiting	Phase 1	psilocybin, mdma	1
Psilocybin Administration With 5-HT1a BlockadeNCT07565493 · Johns Hopkins University	Recruiting	Early Phase 1	psilocybin	1
Effects of Psilocybin in Patients With Amyotrophic Lateral SclerosisNCT06656702 · Johns Hopkins University	Recruiting	Early Phase 1	psilocybin	1
Psilocybin for Depression in People With Mild Cognitive Impairment or Early Alzheimer's DiseaseNCT04123314 · Johns Hopkins University	Recruiting	Early Phase 1	psilocybin	1
RCT: Fentanyl Plus Ketamine Versus Fentanyl Alone for Acute Burn PainNCT03305055 · Johns Hopkins University	Terminated	Phase 4	ketamine	1
Psilocybin Treatment of Major Depressive Disorder With Co-occurring Alcohol Use DisorderNCT04620759 · Johns Hopkins University	Active, not recruiting	Phase 2	psilocybin	1
Inpatient Buprenorphine Induction With Psilocybin for Opioid Use DisorderNCT06005662 · Johns Hopkins University	Withdrawn	Phase 2	psilocybin	1
Trifecta Research StudyNCT06810765 · Johns Hopkins University	Withdrawn	Phase 2	dmt, ibogaine	1
Psilocybin for Opioid Use Disorder in Patients on Methadone Maintenance With Ongoing Opioid UseNCT05242029 · Johns Hopkins University	Withdrawn	Phase 2	psilocybin	—
Effects of Psilocybin in Major Depressive DisorderNCT03181529 · Johns Hopkins University	Completed	Phase 2	psilocybin	1
Persisting Effects of PsilocybinNCT02971605 · Johns Hopkins University	Completed	Phase 1 / Phase 2	psilocybin	1
Psychopharmacology of Psilocybin in Cancer PatientsNCT00465595 · Johns Hopkins University	Completed	Phase 2	psilocybin	1
Safety for Home Administration of Microdose Psilocybin UseNCT06450210 · Johns Hopkins University	Completed	Phase 1	psilocybin	1
Psilocybin Brain Stimulation and Imaging Pilot StudyNCT06835699 · Johns Hopkins University	Completed	Phase 1	psilocybin	1
Shortened LSD Intervention for Major Depressive DisorderNCT07503002 · Johns Hopkins University	Not yet recruiting	Phase 1	lsd	1
A Study of Psilocybin for PTSDNCT06407635 · Johns Hopkins University	Active, not recruiting	Phase 1	psilocybin	1
PRoMiSS: Psilocybin and the Role of Music in Set and SettingNCT07180108 · Johns Hopkins University	Enrolling by invitation	Phase 1	psilocybin	1
Effects of Psilocybin in Post-Treatment Lyme DiseaseNCT05305105 · Johns Hopkins University	Completed	Phase 1	psilocybin	1
Effects of Psilocybin-facilitated Experience on the Psychology and Effectiveness of Professional Leaders in ReligionNCT02243813 · Johns Hopkins University	Completed	Phase 1	psilocybin	1
Safety and Tolerability of Psilocybin in Post-Traumatic Stress DisorderNCT05562973 · Johns Hopkins University	Withdrawn	Phase 1	psilocybin	—
Effects of Psilocybin in Anorexia NervosaNCT04052568 · Johns Hopkins University	Completed	Phase 1	psilocybin	1
Effects of Psilocybin on Behavior, Psychology and Brain Function in Long-term MeditatorsNCT02145091 · Johns Hopkins University	Completed	Phase 1	psilocybin	1
Psilocybin and Spiritual PracticeNCT00802282 · Johns Hopkins University	Completed	Phase 1	psilocybin	1
Pilot Study: Effects of Psilocybin on Behavior, Psychology and Brain Function in Long-term MeditatorsNCT01988311 · Johns Hopkins University	Completed	Phase 1	psilocybin	1
Effects of Psilocybin in Obsessive Compulsive DisorderNCT05546658 · Johns Hopkins University	Active, not recruiting	Early Phase 1	psilocybin	1
Psilocybin-facilitated Smoking Cessation Treatment: A Pilot StudyNCT01943994 · Johns Hopkins University	Completed	Not applicable	psilocybin	2

Sponsor attribution is the lead sponsor recorded on ClinicalTrials.gov API v2. Collaborators are not counted here. Data build 2026-08-25.